Upload
others
View
0
Download
0
Embed Size (px)
Citation preview
Investor Presentation
Oct 2018
2
Disclaimer
These slides have been prepared by Bomi Italia S.p.A. (“Bomi”, the “Company” and together with its subsidiaries the “Group”), solely for a presentation of the Company’s major economic drivers, without
any guarantee or representation, thus resulting in a mere estimation of the current and prospective results.
These slides are strictly confidential and are being shown to you solely for your information. Neither this document nor any copy thereof may be reproduced, further distributed to any other person or
published, in whole or in part, for any purpose. By attending this presentation, you are agreeing to be bound by these restrictions. Any failure to comply with these restrictions may constitute a violation of
applicable laws.
The information contained in this document (“Information”) has been provided by the Company or obtained from publicly available sources and has not been independently verified by BPER Banca
S.p.A. (“BPER”) nor from any other auditing firm.
None of the Company, BPER or any of their respective affiliates, directors, officers, advisers, agents or employees, nor any other person make any representation or warranty, express or implied, as to,
and no reliance should be placed on, the fairness, accuracy, materiality, completeness or correctness of the Information or any opinions contained herein. This presentation may contain financial
information and/or operating data and/or market information regarding the business, assets and liabilities of the Company and its subsidiaries and the results of operations and markets in which the
Company and its subsidiaries are active. Such financial information may not have been audited, reviewed or verified by any independent accounting firm and/or such operating or market information may
be based on management estimates or on reports prepared by third parties which neither the Company nor the BPER have independently verified. BPER has not made an independent evaluation or
appraisal of the business, assets or liabilities of the Company or any of its subsidiaries. It is not the intention of the Company or of BPER to provide, and you may not rely on these materials as providing,
a complete or comprehensive analysis of the Company’s financial or trading position or prospects. This presentation speaks as of its date and will not be updated. The Information included in this
presentation may be subject to updating, completion, revision and amendment and such Information may change materially without notice. No person is under any obligation to update or keep current
the Information contained in this presentation and any estimates, opinions and projections expressed relating thereto are subject to change without notice. Neither the Company or BPER, nor any of their
respective affiliates, directors, officers, advisers, agents or employees, nor any other person shall have any liability whatsoever (in negligence or otherwise) for any loss howsoever arising from any use
of these materials or its contents or otherwise arising in connection with this presentation. Any projections, estimates, forecasts, targets, prospects, returns and/or opinions contained in this presentation
involve elements of subjective judgment and analysis and are based upon the best judgment of the Company as of the date of this presentation. No representation or warranty is given as to the
achievement or reasonableness of, and no reliance should be placed on, any valuations, forecasts, estimates, opinions and projections contained in this presentation. In all cases, recipients should
conduct their own investigation and analysis on the Company and the Information contained in this presentation.
THIS PRESENTATION AND ANY RELATED ORAL PRESENTATION DOES NOT CONSTITUTE AN OFFER OR INVITATION TO SUBSCRIBE FOR, PURCHASE OR OTHERWISE ACQUIRE ANY
SECURITIES AND NOTHING CONTAINED HEREIN OR ITS PRESENTATION SHALL FORM THE BASIS OF ANY CONTRACT OR COMMITMENT WHATSOEVER. ANY DECISION TO PURCHASE
SECURITIES IN THE CONTEXT OF AN OFFERING SHOULD BE MADE ON THE BASIS OF INFORMATION CONTAINED IN THE ADMISSION DOCUMENT (DOCUMENTO DI AMMISSIONE) IN
ITALIAN LANGUAGE PUBLISHED IN RELATION TO SUCH AN OFFERING AND/OR ON THE FOLLOWING PRESS RELEASES, FINANCIAL REPORTS AND OTHER INFORMATIONS THAT HAD
BEEN ISSUED BY THE COMPANY, FROM ITS LISTING TO PRESENT DATE.
This Information contained in this document and any related presentations is being distributed to and is directed only at persons in Member States of the European Economic Area (“EEA”) who are
“qualified investors” within the meaning of Article 2(1)(e) of the Prospectus Directive (Directive 2003/71/ec) (“qualified investors”). Any person in the EEA who receives this document will be deemed to
have represented and agreed that it is a qualified investor. Any such recipient will also be deemed to have represented and agreed that it has not received this document on behalf of persons in the EEA
other than qualified investors or persons in the UK, Italy and other member states (where equivalent legislation exists) for whom the investor has authority to make decisions on a wholly discretionary
basis. The company, BPER and their affiliates, and others will rely upon the truth and accuracy of the foregoing representations and agreements. Any person in the EEA who is not a qualified investor
should not act or rely on this document or any of its contents. The Information contained in this document is not for publication, release or distribution in Australia, Canada or Japan. The distribution of
this document and any related presentation in other jurisdictions may be restricted by law and persons into whose possession this document or any related presentation comes should inform themselves
about, and observe, any such restriction. Any failure to comply with these restrictions may constitute a violation of the laws of any such other jurisdiction. This document may not be acted on or relied on
by persons who are not eligible to invest in securities offered. Any investment or investment activity to which this communication relates is available only to persons eligible to invest in securities and will
be engaged in only with such persons.
Agenda
1.0
2.0
3.0
3
About Bomi
Key Financials
Bomi Investment Opportunity
Our Vision 1.1
4
Strive to become the N°1 partner
to the Healthcare Industry.
Intelligence first,
Delivery after,
Customer Care always.
Bomi Group key drivers 1.2
5
Global
Presence
Customer
Loyalty
Beyond
Logistics
Bomi Group offers to its
multinational customers a
well-established
NETWORK COVERING
20 COUNTRIES,
managed by talented and
specialized teams.
Bomi focuses on a
HIGH-VALUE ADDED MARKET
that rewards strong compliance
with regulatory and
customized services.
This turns into remarkable
bluechip customer loyalty.
In addition to its Core Business Division,
Bomi Group offers a range of
CUSTOMIZED & INNOVATIVE SERVICES.
These include Home Care
Deliveries, Hospital Logistic Management
and Virtual Branch.
Global presence serving a growing market 1.3
6
Mediterranean:
Italy, Spain, Turkey
Northern Europe
France, Netherlands,
Russia
China North America:
US
South America:
Mexico, Argentina, Brasile,
Chile, Peru, Colombia,
Panama
APAC:
Singapore (HQ).
T World Medical Market: 423 mld USD
CAGR 16-21: +5,6%
China: +9,9%
APAC: +6,7%
LATAM: +9,1%
West EU: +6%
Source: BMI Research, Dec. 2017
More than 100 clients 1.4
7
Medical
Devices Implantables Chronic disease
treatments
In Vitro
Diagnostics
Pharma &
Food
supplements
Biotech
Home
Patients
Healthcare
Companies Hospitals Clinics Labs
Bomi cooperates with almost 90% of the most important multinational companies operating in
the Healthcare field, managing every kind of medical device and being involved in all the steps of
the healthcare supply chain.
1.5
8
Service portfolio
1.6
9
Service portfolio
Safe storage of any kind of healthcare product on behalf
of manufacturers in licensed, secure and monitored
locations under the strict observation of the quality
standards and local regulations.
• 40 Bomi Group warehouses worldwide
• 185.000 sqm of dedicated storage space.
• Ambient and controlled temperature warehouses
• Labelling & kitting activities
BOMI Health Carrier is the BOMI brand fully devoted to ambient and controlled temperature deliveries of Healthcare products, including emergency deliveries 24/7 of life-saving devices. • Deliveries to hospitals, home patients, pharmacies and laboratories.. • Leadership in the Home Care channel, addressed to the management of chronic disease.
1.7
10
Service portfolio
Value-added solutions – beyond standard logistic
services - to provide stable and long-lasting support to
our healthcare clients. Some examples are
Pharmaceutical Labs for the processing of secondary
packaging of pharma, food supplements and Virtual
Branch service (plug&play solutions to enter new
markets).
Since 2006, Bomi has been offering specific solutions for managing Hospital inventories, servicing both manufacturers and clinics, with the complete traceability of stock levels and reconciliation for the clients.
Strategic positioning: Bomi’s uniqueness 1.8
11
SP
EC
IAL
IZE
D
GE
NE
RA
LIS
T
LOCAL INTERNATIONAL
MIT (Dhl)
Due Torri
Fercam
Almacenar
Multipack
Shuttle
Ceva
UPS
DHL
FedEx
Kuehne + Nagel
Chiapparoli Logistica
AGV
Open Market
Andreani
Eurodifarm (Dhl)
Movianto
Xpo
Logista
Arvato (Bertelsmann)
In recent years there has been a steady M&A activity within the industry, as major generalist players
are willing to find vertical solutions to the healthcare sector.
Bomi’s other competitors are its potential customers, which can operate in the market using a
strategy of insourcing.
Market
trends Generalist
suppliers
Strategic approach Tactical approach
GE
NE
RA
LIS
T
SP
EC
IAL
IZE
D
Customer orientation
High levels of customization
Market-driven approach
Target: multinational
companies and industry
leaders
Global presence
1.9
12
A solid strategic path, with a view on MTA/Star
2014 Pre IPO
New activities in France,
Russia, Netherlands,
Peru, USA. Licencee in
China.
Issued a Pre-IPO
incentive bond of €1.5m
listed at segment
ExtraMot-Pro of Borsa
Italiana.
Got ELITE certificate
from Borsa Italiana
Bomi Group buys
80% of G. Carrai ,
becoming market
leader in Home
Care dialysis
deliveries in Italy,
and acquires Ritmo
Holding B.V, logistic
and transport
company in the
Netherlands
2015
30 years of activity.
Listing to the AIM
market Milan
2015
Bomi Group starts
operation
in Panama and
enters directly the
Chinese market.
Bomi Group creates
a new JV with
Distritec, French
Transport company
2016
Bomi acquires Logik
Trans Srl based in
Rome (June) and
Berga Srl based in
Modena (Oct.) to
strengthen its
transport network
2016
Bomi Group enters
directly the Mexican
market and
acquires the
remaining 20% of
G.Carrai
2017
Bomi Group
announces the
acquisition of the
minority stake in its
Brazilian subsidiary
2017
Bomi Group
acquires De Salute
Srl, a logistic player
specialized in the
pharmaceutical
sector and acquires
the remaining 20%
of Biocarrier and an
additional 10% of
Biomedical
Colombia
2018
Bomi Italia
announces two
important news into
the Articles: Loyalty
shares and
exemption from the
mandatory public
tender offer for
consolidation
effective from “step-
up” to the regulated
market.
2018
Bomi Italia
announces a share
capital increase of
up to Euro 4.99
million, successfully
completed, to reach
additional growth
and a Board
mandate to further
increase the share
capital for a
maximum total of
Euro 12 mln (within
five years).
2018
…NEXT STEP
MTA
MARKET…..
18 July 2018 - Bomi
Group announces
the acquisition of
Farma Logistica
S.r.l.
2018
Agenda 0.0
1.0
2.0
3.0
13
About Bomi
Key Financials
Bomi Investment Opportunity
Revenue Trend 2.1
14
Steady Historical Turnover growth, without M&A &
Newco, (CAGR ~ 10%) along the past 13 years,
despite the devaluation of the Brazilian real in recent
years.
Revenue composition balanced in the past 3 years,
thanks to the growth in Europe, resulting in a risk
mitigation in term of macro trends.
New Subsidiaries contribution is expected to increase
(in particular LATAM) 0,00
1,00
2,00
3,00
4,00
5,00
-
20.000
40.000
60.000
80.000
100.000
120.000
140.000
Bomi Group Sold Turnover Growth from M&A & Newco
Historical Turnover Avg Exc.Rate R$/€
Lineare (Historical Turnover)
The LATAM companies, at constant rate, increased their
revenues by 16% compared to first half 2017, mainly due
to organic growth.
Revenues in Europe increased by 25% compared to first
half 2017 due to De Salute company, acquired in January
2018.
49%
45%
4% 2%
1°st half 2018: Revenues by Region
Emea
Latam
Row
Apac
2018-06: lead indicators of Bomi Group results 2.2
15
Revenues rose by approx 5,9% compared to first half
2017. At constant rate 2017 revenues increased by
15% due to internal growth (about 6%) and the
inclusion in the consolidation area of De Salute
(about 9%).
Ebitda rose by approx 11,5% , at constant rate first
half 2017, compared to first half 2017.
Net earnings Bomi Group first half 2018 increased by
51%, at constant rate, compared to first half 2017,
The growth in net earnings Bomi Group is also
related to the strategy of consolidation of the
minorities.
+15% vs 2017
€ 6,3
€ 5,6 € 5,5
2
3
4
5
6
7
First half 2017 First Half 2018
Mio
EBITDA (constant exc.rate) EBITDA
0,00
0,20
0,40
0,60
0,80
1,00
1,20
1,40
1,60
1,80
30/06/2017 30/06/2018 30/06/2018 ex rate 2017
Net Earnings Net Earnings Bomi Group
€ 59 € 62 € 67
-6,0%
-1,0%
4,0%
9,0%
14,0%
€ -
€ 10
€ 20
€ 30
€ 40
€ 50
€ 60
€ 70
30/06/2017 30/06/2018 30/06/2018 ex rate
2017
Mio
Revenues Ebitda Margin
1° half 2018: NFP Bridge and Composition 2.3 OPERATIONAL
CASH FLOW
Cash-flow generated
from the operational
activity DELTA NWC Due to the growth of
revenues and
seasonality
M&A
primarily represented
by the acquisition of
De Salute and others
minorities
25,5
3,8 2,4 3,2
4,6 4,7 1,3 1,0
29,5
0,00
5,00
10,00
15,00
20,00
25,00
30,00
35,00
NFP 2017 Operational cash flow
Delta NWC Operative Investments
M&A Investments
Capital Increase
NFP Newco Others NFP 1st half 2018
Mili
on
i
CAPITAL
INCREASE
July 1°, 2018 Bomi
closed a Capital
Increase fully
subscribed
(35) (30) (25) (20) (15) (10) (5) 5 10 15 20 25 30 35 40
Cash & Equivalents
Short term Bank debts & Factors
Mid Term Loans
Leasing
Dividends due to minorities
Convertible Bond
Vendor Loan
Financial receivable
NFP BREAKDOWN
1° half 2018: Financial Debt payments plan 2.4
60,7
6,0
11,3
11,7
10,3
12,9
7,0 1,5
(32,3)
,00
10,00
20,00
30,00
40,00
50,00
60,00
70,00
0,00
10,00
20,00
30,00
40,00
50,00
60,00
70,00
No convertible financial debts
2018 II half 2.019 2.020 2.021 2.022 2.023 >= 2024 Cash and equivalent
Mili
on
i
NOTE: The payments due up to 2020 are fully covered by Cash and Equivalent presents at first half
2018.
Agenda 0.0
1.0
2.0
3.0
18
About Bomi
Key Financials
Bomi Investment Opportunity
To sum up 3.1
19
Strong customer loyalty
Increasing margins on a
growing Business Model
Market leadership in
Latin America & Italy
Multinational presence is a key winning factor.
Bomi Group has market leadership or co -
leadership in Brazil, Colombia, Peru and Italy and
a unique network to serve Latin America.
The recent new initiatives are starting to
show a postive EBITDA contribution
Present Company set-up has a remarkable
over capacity
Upside opportunities
through M&A activities
The potential business combination with a
high-margin target might result in outstanding
business perfomances
Bomi Group relatively low debt levels could fit
to a new development stage
The outstanding blue-chip customer loyalty
might generate cross-selling opportunities within
the Network
Strategic Milestones 3.2
20
Vertical Market
Consolidation
Game changing
acquisitions
Bomi 4.0
Focus on new acquisitions to increase
Bomi group vertical capabilities and scale
in present markets
- Robotics and Automation
- Go GREEN
- Innovative Services
- Remote Healthcare
Plan to identify a potential transformational
deal within 9-12 months thus activating the
€ 12million Capital Increase/Convertible
Bond upon decision of Bomi’s BoD
4€m
1€m
12€m
© Bomi Group Company, 2018
www.bomigroup.com